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Technical Report
Abstract
Purpose: The purpose of this study was to establish Machine performance check(MPC) application as a comprehensive daily QA program in a clinical setting for aTrue Beam 2.0 system and investigate the first ten months (195 days) daily QAdata generated by the MPC. Methods: An automated daily quality assurance (QA)application named machine performance check (MPC) was recently launched byVarian Medical Systems with their TrueBeam 2.0 linear accelerator (linac) system.MPC performs all the essential machine tests such as Beam Constancy Check, andGeometry Check with the use of an IsoCal phantom. There is no systematicpublished study on long-term consistency and validation of MPC in a clinical set-upfor its acceptance as an alternative QA application. In the present study, wecollected data with the MPC for over ten months (195 days) on a TrueBeam 2.0system. The data was analysed for reproducibility and also compared with the datacollected with other statndard QA devices at the time of commissioning of theTrueBeam system for validation. Results: The results showed that thereproducibility of MPC was at least an order of magnitude less than the tolerancevalues for the respective parameters and also the average measured values for allQA parameters studied. The MPC measured isocenter accuracy, and output valueswere close to the Winston-Lutz test (within 0.1 mm) and the ion-chambermeasurements (within 0.1%), respectively. Conclusion: With our long term result,it is evident that the MPC could be an alternative daily QA tool. A comprehensiveand long-term validation of the MPC measured values with the other standard QAmethods over the ten month period will be needed before accepting MPC as areliable QA tool.
Keywords: Radiotherapy, Machine Performance Check (MPC), TrueBeam 2.0,Linac QA
1. IntroductionIn recent times a trend towards increasing use ofcomplex dose delivery technologies such as volumetricmodulated arc therapy (VMAT), flattening filter free(FFF) photon beams and on-board imaging (OBI) inmodern radiotherapy centers has been witnessed.Coupled with the increase in hypo-fractionationprotocols, there is a need for greater emphasis on moreelaborate, and frequent quality assurance (QA) tests toensure that the radiotherapy equipment is functioningconsistently within the stated specifications. Needless tosay, the tools required to implement such QA protocolsshould be convenient, quick and efficient. To achievethese objectives innovations have continued in QA
hardware and software technologies for their wideracceptability in clinical set-ups.An automated QA application tool named machineperformance check (MPC) was introduced by VarianMedical System with their linear accelerator (linac)TrueBeam 2.0 in 2015 for clinical use. The MPC utilizesthe kV and MV imaging of the linac system along with awell-established phantom (IsoCal) to perform a set ofQA tests and present the results in a simple ‘pass/fail’form. The recommendations of the AmericanAssociation of Physicists in Medicine (AAPM) task groupreport 142 (TG 142) have been the basis for setting up
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the QA tests within the MPC application.1,2 The MPC ismeant for a reliable and fast system testing on a dailybasis before commencing patient treatment withmodalities such as intensity modulated radiotherapy(IMRT), VMAT, stereotactic radiotherapy (SRT) andstereotactic body radiotherapy (SBRT) on the treatmentdelivery platform.There is a lack of literature on systematic long-termconsistency evaluation and validation of the MPC in aclinical environment. Clivio et al. used a pre-release MPCversion and performed the QA sequences on a VarianResearch Beam functionality for ten repetitions (10days).3 We decided to systematically study the long-termperformance of the clinical MPC version 1.0 MR1 on arecently commissioned TrueBeam 2.0 system. Weevaluated the reproducibility of the acquired data forboth dosimetric and mechanical test parameters for 195days, spread over ten months and also compared MPCresults with standard QA methods such as theWinston-Lutz for isocentric accuracy test at the time ofcommissioning and ion-chamber measurements for doseoutput on weekly basis of the TrueBeam system. Webelieve that our study carried out over a period of tenmonths in a clinical environment will help the otherusers to integrate the MPC in their daily QA programmewith increased confidence. However, being apreliminary study the emphasis was mainly onlong-term reproducibility of the results and also on easeof integration of the MPC with the departmentalworkflow. In the next phase of our work, we plan tovalidate all the MPC measured parameters with theother well-established methods over a longer period asper availability machine time in a busy clinicaldepartment.
2. Methods and Materials
2.1. TrueBeam 2.0The TrueBeam Version 2.0 linac system with the MPCapplication is manufactured and supplied by VarianMedical Systems (Palo Alto, USA). The linac providesthree flat and two flattening filter free (FFF) photonbeam energies. It is equipped with a multileaf collimator(MLC) with 120 leaves (millenium MLC). The MLC hascentral 40 leaf pairs with leaf width of 0.5 cm and outer20 pairs with leaf width of 1.0 cm at isocenter covering afield size from 0.4 × 0.4 cm2 to 40 × 40 cm2. The linacsystem has kV and MV imaging features usingamorphous silicon type flat-panels. The kV imagingincludes fluoroscopy and cone beam CT (CBCT) features.The Linac couch has 6-degrees of freedom namely threelinear and three rotational. For additional technicalspecifications of the TrueBeam 2.0 system, one mayrefer to the relevant Varian technical catalogues.4,5
2.2. The Machine Performance Check (MPC)
Application
The MPC is an automated application having pre-definedprotocols for performing a set of daily QA tests. Thesequence of measurements within the MPC applicationis initiated from the desktop of the linac consoleworkstation. IsoCal phantom, also from Varian, isutilized to perform some of the QA tests included in theMPC protocol. The Phantom is a hollow cylinder of 23cm diameter and height with 16 tungsten-carbidespheres (of 4 mm diameter) located in a knowngeometrical pattern on the surface of the phantom.6After mounting the IsoCal phantom on the linaccouch-top using the indexing system of the couch, theMPC QA procedure needs to be activated from theTrueBeam console menu using the displayed MPC icon.The couch then moves to a known position as per theprotocol, and this position is used as a reference positionfor the all the tests. The MPC application software listsall the scheduled checks to be performed during thesession and displays instructions to be followed in asequence. Once the photon beam energy for the tests isselected, the kV and MV detector panels get deployed atthe pre-defined positions. With the switching on of theselected photon beam, the data acquisition in terms ofkV and MV planar images starts for variouscombinations of the gantry, couch and collimator anglesand field size settings.7-10 The acquired images areinstantaneously processed and analyzed for thedosimetric and geometric QA parameters.A total of 39 planar images, both the MV and the kVones, are acquired as per the pre-defined MPC protocolfor analysis with the built-in MPC software. Of the 39images, 12 are acquired using the kV imager with theIsoCal phantom and 27 are with the MV imager. Theinitial 8 MV images of the 27 images are without theIsoCal Phantom, and the rest are acquired aftermounting the phantom on the couch. The first five ofthese MV images are utilized for beam center check andthe sixth and seventh ones are for beam profile checkand beam profile ratio, respectively. Four kV imagesacquired at gantry angle 0° and four MV images atgantry and collimator angles 0° each with the IsoCalphantom are used for the couch check. Another set ofeight kV images at gantry angles 360°, 45°, 90°, 135°,180°, 315°, 270° and 225° is acquired with the IsoCalphantom for kV isocenter measurement and a series ofMV image pairs (08) at gantry angles 360°, 45°, 90°,135°, 180°, 315°, 270° and 225° and collimator angles 0°and 90°, is acquired with the IsoCal phantom fortreatment isocenter and gantry position measurement. Atotal of 247 MUs are delivered during the entire MPCprocedure, and the procedure takes approximately 5minutes for one photon energy. We carried out the studywith 6 MV photon beam, and the data was collected for aperiod of ten months (195 days). The MPC QAprocedure, which can be divided into two categoriesnamely dosimetry checks and geometry checks, isdescribed below:
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2.2.1. Dosimetry checks/beam consistency checksThese checks are performed with a field size of 18 × 18cm2 at 0° gantry angle utilizing a fixed number ofmonitor units (32 MU) without the IsoCal phantom. Theplanar image obtained is compared with the baselineimage acquired at the time of commissioning of the linacsystem to estimate the deviations of various dosimetricparameters. To reduce the impact of the jaw positioninguncertainty (a geometric parameter) on the beamdosimetric parameters, the latter are estimated for aninner area of the field (13.3 × 13.3 cm2) at the isocenterwherever necessary. MPC uses the high-quality MVimaging mode for acquisition, and this imaging mode iscalibrated at the time of commissioning, and routinelyon a monthly basis, otherwise an error message isdisplayed. For the beam constancy check MPC acquires adark field and retrieve the pixel defect map, both areapplied to the raw MV image. The EPID was alsodosimetrically calibrated before the using MPC at thetime of commissioning.
2.2.1.1. Output changeIt represents the average percentage change withrespect to the baseline value in the detector response inthe central area of the imager. As the present dayelectronic portal imaging device (EPID) technology hasbecome robust and stable, the estimated output valuesfor photon energies with it are assumed to be influencedprimarily by changes in the beam characteristics.11-14
2.2.1.2. Radiation field uniformity changeThe uniformity of a photon beam is conventionallyestimated from the transverse beam profiles. However,in the case of a 2D portal image, the beam uniformity isdefined as the ratio of the maximum and minimum pixelintensity values observed in the inner area of the field.The change in radiation field uniformity represents thepercentage variation of uniformity between the currentand the baseline value. While estimating beamuniformity, the high-frequency noise is filtered.
2.2.1.3. Center shiftThe center shift describes the relative shift of the fieldcenter defined by the collimator jaws with respect to thebaseline. The field center is established through thedetection of the jaw edges in the beam image. The shiftrepresents a summary value on the precision of thebeam steering system, the collimation, and the MVimaging system.
2.2.2. Geometry checksThe geometry checks evaluate the positioning accuracyof the various mechanical axes of the TrueBeam system.
2.2.2.1. IsocenterThe isocenter is defined as the ideal intersection point ofthe beam’s central axis over the full gantry rotation. Thecentral axis in the MPC application is defined by thecenter of the rotation of the highest priority collimating
device, i.e. the MLC. The treatment isocenter isdetermined from the data acquisitions on eightrepresentative gantry angles namely 45°, 90°, 135°,180°, 225°, 270°, and 315°. The size of the treatmentisocenter is defined as the maximum distance of thebeam’s central axis from the idealized isocenter.
2.2.2.2. MV and kV imager offsetsThe imager projection offset represents the maximumdistance of the imager center from the projection oftreatment isocenter localized with the help of the leadballs placed on the IsoCal phantom. A low value ofimager offsets is important for CBCT image quality andimage matching during IGRT process.
2.2.2.3. CollimatorThe positional accuracy of the collimation system isdetermined from the static field evaluation at 0°gantryposition. The position of the individual collimator jaws isdefined as the line along the edge of the steepestgradient on the acquired MV images. The jaw offsetvalues are measured as the distance of the jaw edgesfrom the center of rotation of the collimator, i.e., thecollimator isocenter.
2.2.2.4. MLCFor positional accuracy measurements of the MLC, astatic comb-like pattern is acquired on the MV imager at0° collimator and gantry angles. The positional accuracyof each MLC leaf is measured as the distance of the MLCleaf tip from the MLCs center line from this irradiationpattern. The center line is defined as the line through thecenter of rotation of the MLC that is perpendicular to theedges of the leaves. The leaf-banks A and B of the central40 MLC leaf pairs alone are analyzed with the MPC.These leaf-pairs are the maximum utilized leaves fortreatment delivery. The maximum and mean offsetvalues are estimated for these two leaf-banks. Also, therotational offset of the MLC that is defined as themaximum deviation of the nominal versus the actualcollimator rotation angle observable through the edgesof the MLC leaves is estimated.
2.2.2.5. GantryThe MPC evaluates two characteristics of the machinegantry positioning system namely absolute and relativeerrors. The absolute positioning accuracy is defined asthe coincidence of the couch vertical axis with thecentral beam axis at 0° gantry angle. By moving thecouch along its vertical couch axis, the MPC evaluatesany lateral or longitudinal shift of the phantom withrespect to the beam, and the treatment isocenter isrecorded as the absolute gantry angle positioning error.For the relative accuracy, the angle of the gantry isevaluated as defined by MV imaging system using thegeometric phantom. The relative positioning error of thegantry is the maximum offset between the angledetermined by the MV imaging system and the nominalgantry angle. The values are compared for eight
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representative gantry angles namely 45°, 90°, 135°,180°, 225°, 270°, and 315°.
2.2.2.6. CouchThe MPC measures the positioning accuracy of thedifferent couch axes with respect to a reference position.The reference position is established in the fixed roomcoordinate system using the MV and kV images with theIsoCal phantom, and the actual travel range of the couchaxes is determined in this reference system. Thepositional accuracies in all the directions namely lateral(5 cm), longitudinal (5 cm), vertical (15 cm), rotational(10°), pitch (3°) and roll (3°) are checked within thetravel ranges mentioned in the brackets. Therotation-induced couch shift describes the distancebetween the center of rotation of the couch determinedthrough a motion on the rotational axes and thetreatment isocenter.
2.3. Defining the baseline valuesAt the time of machine commissioning all the geometricand dosimetric parameters of the TrueBeam 2.0 systemwere measured as per the laid down procedures withstandard QA methods such as the Winston-Lutz forisocentric accuracy test, ion-chamber measurements fordose output, MLC positioning accuracy with picket fencetest, and geometric accuracy of collimator etc.Simultaneously, corresponding parameters were alsomeasured with the MPC for use as baseline values.
2.4. Evaluation of reproducibilityThe reproducibility of the MPC application for each ofthe measured parameter over a period of ten months(195 days) was evaluated in terms of standarddeviation. It was felt that because of the absolute valuesof some of the measured parameters, especially thegeometric ones were quite small (< 1 mm or < 0.1°),stating the reproducibility in the usual percentage termsmay not represent a meaningful interpretation relevantto actual radiotherapy delivery in clinics. Therefore,reproducibility of the MPC data was analyzed anddiscussed in terms of absolute or relative values as perthe clinical relevance of each parameter value.
2.5. MPC response to machine output variationAn F65 Farmer-type ion chamber of active volume 0.65cm3 with Dose-one electrometer and a solid (Perspex)plate phantom (SP33), all from IBA Dosimetry System(Schwarzenbruck, Germany), were used for outputmeasurements. The source to surface distance (SSD) waskept at 100 cm, and the ion chamber was placed at adepth of 10 cm. The output of the machine was set to 1cGy = 1 MU for each photon energy at its respective dmaxfor a 10 cm × 10cm field size. This output test of the linacsystem was performed with the 15 MV photon beam.The output was varied in 11 steps of known step size(± 0.5 % of the monitor gain) in the service mode. Thefirst five steps decreased the output from 0 to -2 %; thenext five increased it from 0 to + 2 % and the last (11th)
step was at the initial value (0 %). The changes in thelinac output thus carried out were measured with theion chamber and the MPC methods.15-16
3. ResultsThe QA data measured and analyzed with the MPC wasfinally displayed as ‘pass’ or ‘fail’ for each parameter in atabular form. The data was depicted in graphical form aswell. The display included a warning, in red for fail andin yellow for near to fail, for a test parameter thatexceeded the pre-set threshold (tolerance) value. Tables1 and 2 show the results of the data collected over aperiod of ten months (195 days) for the geometric anddosimetric parameters, respectively, for a 6 MV photonbeam. The trend is also shown graphically in figure 1. Itmay be noted that for any test involving IsoCal phantom,if the phantom was incorrectly fixed and moved duringcouch motion on the table-top, it may cause incorrectMPC test result. Thus an erroneously fixed phantom mayinfluence the final measured values, so IsoCal phantommust be affixed firmly enough that it does not moveduring the test. Figure 2 shows the output changes (%)measured with the ion-chamber and the MPC.
4. Discussion
4.1. Geometric ChecksAs seen in Table 1, the average isocenter size measuredwith the MPC for the ten month study period iscomparable with the independently measured valueusing Winston-Lutz test carried out with the help ofIsolock software tool provided by Varian. It may bementioned here that the Winston-Lutz test wasperformed at the time of acceptance testing of the linacsystem. The MPC value for the isocenter estimated onthe same day as the Winston-Lutz test, therefore, servedas a benchmark for the following MPC values. The MVand kV isocenter offset values also passed the tests. Gao
et al. carried out a detailed study of the geometriccalibration with IsoCal phantom using OBI and EPIDimaging systems (IsoCal test) and compared theirresults with a simplified Winston-Lutz based test and aVarian cubic phantom based test for Varian linacs. Theyconcluded that the IsoCal is an accurate and consistentmethod for calibration and periodic quality assurance ofMV and kV imaging systems. We designed our ownprotocol for imager offset correction. As per the protocolif the MPC values were found to be beyond tolerancelevel set by us (± 0.5 mm), then the IsoCal test was to beused for independent verification of the result. Onconfirmation of the result with the IsoCal test, offsetcorrection in terms of physical adjustment of the imagerwas to be effected.The collimator rotation values, as well as jaw offsetvalues, were well within the tolerance limits except forthe Y1 jaw for which the value was in the danger zone.This result was validated with the help of anindependent radiochromic film based test and the Y1
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jaw offsets error was accordingly corrected. Themaximum offsets of the leaf banks A and B of the MLCwere also well within the tolerance values. Similarly, thecouch related parameters, including the rotationinduced couch shift, were well within the tolerancelimits. The absolute and the relative values for gantryangles were found within limits. As for thereproducibility of the geometric parameter values
measured over the ten months (195 measurements)study period, the standard deviation in absolute terms isat least one order of magnitude less than 1 mm for thedistance parameters and two orders of magnitude lessthan 1° for the angular parameters. The small spread inthe day to day variations depicted in figure 1 (A-D) forten months is a visual indication of the acceptablereproducibility of the data.
Table 1:MPC geometry check report for a 6 MV photon beamParameter Test procedure Value( Mean±SD) Thresholdvalue Pass/fail
IsocenterIsocenter size (mm) MPC 0.384±0.011 ± 0.50 PassWinston-Lutz 0.297Isocenter MV offset (mm) MPC 0.286±0.049 ± 0.50 PassIsocenter kV offset (mm) MPC 0.185±0.042 ± 0.50 PassCollimatorCollimator rotation offset (°) MPC 0.265±0.025 ± 0.50 PassCollimator Jaw X1 (mm) MPC -0.008±.027 ± 1.00 PassCollimator Jaw X2 (mm) MPC 0.615±0.021 ± 1.00 PassCollimator JawY1 (mm) MPC -0.352±0.017 ± 2.00 PassCollimator JawY2 (mm) MPC 0.26±0.084 ± 2.00 PassCollimator MLC max offset A (mm) MPC -0.231±0.036 ± 1.00 PassCollimator MLC max offset B (mm) MPC 0.513±0.020 ± 1.00 PassCollimator MLC mean offset A (mm) MPC -0.125±0.036 ± 1.00 PassCollimator MLC mean offset B (mm) MPC 0.327±0.019 ± 1.00 PassCouchCouch lateral (mm) MPC 0.014±0.030 ± 0.70 PassCouch longitudinal (mm) MPC 0.001±0.023 ± 0.70 PassCouch pitch (°) MPC -0.024±0.006 ± 0.10 PassCouch roll (°) MPC -0.035±0.007 ± 0.10 PassCouch rotation (°) MPC -0.089±0.007 ± 0.40 PassCouch vertical (mm) MPC -0.012±0.038 ± 1.20 PassRotation induced couch shift (mm) MPC 0.261±0.041 ± 0.75 PassGantryGantry angle absolute (°) MPC -0.106±0.018 ± 0.30 PassGantry angle  relative (°) MPC 0.051±0.056 ± 0.30 PassSD: Standard Deviation; MPC: Machine Performance Check application
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Table 2: Beam constancy check results for a 6 MV photon beamParameter Test procedure ValueMean± SD Thresholdvalue Pass/failBeam output change (%) MPC -0.228±0.449 ± 2.00 Pass
Ion-chamber -0.315±0.514
Beam center shift (mm) MPC 0.147±0.072 ± 0.50 PassBeam uniformity change (%) MPC 0.914±0.360 ± 2.00 PassMPC: Machine Parameter Check application; SD: Standard Deviation
Figure 1: Screenshots of the MPC geometry test for ten months data trends: (A) Isocenter size, isocenter MV offset,and isocenter kV offset, (B) Collimation MLC maximum offset and mean offset of leaf banks A and Bank B, (C) Gantryabsolute and relative test, (D) Couch rotation, pitch and roll.
4.2. Dosimetry ChecksDosimetry or beam constancy checks were performedfor the 6 MV photon beam as this is the most clinicallyused energy for IMRT, VMAT, and SRS/SRT procedures.The ion chamber measured output values closely matchthe MPC values as shown in Table 2 (p-value 0.001). Thebeam center shift and beam uniformity- change datatrend for the 195 days showed that both of theseparameters had very small values of standard deviation.It was estimated at ± 0.072 mm and ± 0.36% for beam
centre shift and beam uniformity change, respectively,confirming the long term stability of MPC response.
4.3. Response of MPC with manually changed
machine outputThe Pearson correlation coefficient between the MPCand ion-chamber measured output change is 0.991(p-value < 0.001) indicating a strong correlationbetween them (Figure 2). The data was analyzed withthe help of SPSS Statistics for Windows, Version 20.0(IBM, USA).
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Figure 2: Linac output changes measured with an ion chamber and the MPC.
5. ConclusionThe study presented here is a preliminary work to testthe long-term consistency and efficiency of the MPCapplication as an automated daily QA application in aclinical environment. From the data analyzed it isevident that the MPC is a stable system for performingthe required geometrical and beam consistency checksas per AAPM task group 142 recommendations. It takesabout five minutes to carry out the daily QA per photonbeam. Integration of the MPC as a quick daily QAapplication seems eminently feasible.The addedadvantage is that the measured data can also be storedfor a later review, reporting, and analyses. As forvalidation of the MPC measured values, this preliminarywork primarily aimed at assessing the long-termstability of the results obtained and hence validationwith independent measurements was limited to a fewparameters only. We plan to carry out a comprehensivevalidation of the MPC in the next phase of our study.
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